Manchester Capital Management’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-69,535
| Closed | -$1.37M | – | 1021 |
|
|
2021
Q3 | $1.37M | Hold |
69,535
| – | – | 0.19% | 75 |
|
|
2021
Q2 | $1.64M | Hold |
69,535
| – | – | 0.23% | 63 |
|
|
2021
Q1 | $1.65M | Hold |
69,535
| – | – | 0.25% | 60 |
|
|
2020
Q4 | $1.39M | Hold |
69,535
| – | – | 0.22% | 69 |
|
|
2020
Q3 | $1.45M | Hold |
69,535
| – | – | 0.23% | 59 |
|
|
2020
Q2 | $1.22M | Hold |
69,535
| – | – | 0.17% | 72 |
|
|
2020
Q1 | $1.14M | Hold |
69,535
| – | – | 0.18% | 63 |
|
|
2019
Q4 | $1.43M | Buy |
69,535
+27,106
| +64% | +$558K | 0.16% | 71 |
|
|
2019
Q3 | $487K | Hold |
42,429
| – | – | 0.06% | 156 |
|
|
2019
Q2 | $558K | Hold |
42,429
| – | – | 0.07% | 139 |
|
|
2019
Q1 | $642K | Buy |
42,429
+9,429
| +29% | +$143K | 0.08% | 125 |
|
|
2018
Q4 | $787K | Hold |
33,000
| – | – | 0.12% | 98 |
|
|
2018
Q3 | $486K | Hold |
33,000
| – | – | 0.07% | 145 |
|
|
2018
Q2 | $787K | Hold |
33,000
| – | – | 0.12% | 99 |
|
|
2018
Q1 | $843K | Buy |
33,000
+14,143
| +75% | +$361K | 0.13% | 81 |
|
|
2017
Q4 | $348K | Buy |
+18,857
| New | +$348K | 0.05% | 153 |
|